Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
2015 · The Lancet Oncology · 245 citations
https://doi.org/10.1016/s1470-2045(15)00414-3
T
Tarik Gheit
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
275
Papers
7.9K
Citations
47
h-index
148
i10-index
Tarik Gheit is an academic researcher from Centre international de recherche sur le cancer. The author has contributed to research in topics: Cervical Cancer and HPV Research & Genital Health and Disease & Head and Neck Cancer Studies. The author has an h-index of 47, co-authored 234 publications.
ORCID: 0000-0001-7088-337XPapers by this author
worksBarriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review
2023 · BMC Public Health · 117 citations
https://doi.org/10.1186/s12889-023-15842-1
Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma
2013 · Journal of Medical Virology · 38 citations
https://doi.org/10.1002/jmv.23866
Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers
2008 · International Journal of Cancer · 37 citations
https://doi.org/10.1002/ijc.23795
Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study
2019 · Papillomavirus Research · 32 citations
https://doi.org/10.1016/j.pvr.2019.01.004
Prevalence of mucosal and cutaneous human papillomavirus in Moroccan breast cancer
2018 · Papillomavirus Research · 30 citations
https://doi.org/10.1016/j.pvr.2018.04.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat